July 27, 2022 

Pharmacists' Reactions to Federal Guidance on Reproductive Drugs

In some states, new federal guidance on dispensing reproductive drugs has left pharmacists in a difficult quandary. Key pharmacy groups say it is unfair for the federal government and states to threaten aggressive action against pharmacies when the issue remains in flux. Find out what the guidance says and how the National Community Pharmacists Association and the American Pharmacists Association reacted.


Expect More Systemic Reactions After Dual COVID-19/Influenza Vaccination

Receiving a COVID-19 mRNA vaccine booster and a seasonal influenza vaccine at the same time is more likely to produce systemic reactions in recipients than getting a booster alone, according to a new study. CDC researchers say their results added to the understanding of the outcomes of simultaneous vaccine administration. Learn more about these study results.

Higher Risk of CVD, Diabetes After COVID-19 Infection

The bad news is that COVID-19 infection puts patients at higher risk of developing cardiovascular disease (CVD) and diabetes, even after the initial infection has subsided and especially in the first 3 months following infection, according to a recent study. The good news is that the higher risk appears to be relatively short term. Read more.


Prolonged Use of PPIs Do Not Increase Mortality Risk

With an increase in the use of proton-pump inhibitors (PPIs) in the past 2 decades, prolonged use of PPIs for gastrointestinal complaints has been linked to a range of adverse effects. According to a new study, higher mortality risk is not one of them, however. Find out how researchers alleviated concerns that long-term use of PPIs could increase death rates.

Facebook   Twitter   USP Google App   USP itunes App
U.S. Pharmacist
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -